|
Dr. Fahim is President and Chief Executive Officerof Nabi Biopharmaceuticals. He most recently served as Chief Operating Officer and General Manager. In May 2003 he was named Senior Vice President Research Technical and Manufacturing Operations of Nabi Biopharmaceuticals and was Vice President of Vaccine Manufacturing Operations upon joining Nabi Biopharmaceuticals in March 2003. His career includes 14 years with Aventis Pasteur from 1987 to 2001 where he was instrumental in developing several vaccines from early research to marketed products. During his tenure there he held the positions of Vice President Industrial Operations; Vice President Development Quality Operations and Manufacturing; Director of Product Development; and head of bacterial vaccines research/research scientist. During the year prior to joining Nabi Biopharmaceuticals Dr. Fahim was an independent consultant working with Aventis Pasteur and other companies worldwide on projects that included manufacturing process improvement quality operations and regulatory issues. From 2001 to 2002 he served as President and Chief Operating Officer of Lorus Therapeutics Inc. a Toronto-based biopharmaceutical company focused on the research and development of cancer therapies. | 